Breaking News Instant updates and real-time market news.

FCX

Freeport-McMoRan

$40.33 /

+0.735 (+1.86%)

10:11
01/26/22
01/26
10:11
01/26/22
10:11

Freeport McMoRan says looking to future with optimism, excitment

Says generated strong cash flow during Q4. Says balance sheet is strong. Says met a series of multiyear complex challenges with great success. Says reached a point where debt is de minimis. Says has the way forward to increase mining rates. Says relationship with Indonesian government is one of cooperation. Says advanced climate initiatives. Comments taken from Q4 conference call.

  • 26

    Jan

OTHER BREAKING NEWS FROM THE FLY

Recommendations
Micron price target lowered to $45 from $50 at Piper Sandler » 21:05
09/29/22
09/29
21:05
09/29/22
21:05
MU

Micron

$50.04 /

-0.95 (-1.86%)

Piper Sandler analyst…

Piper Sandler analyst Harsh Kumar lowered the firm's price target on Micron to $45 from $50 and keeps an Underweight rating on the shares after its results and outlook. The company's Q2 revenue guidance miss was due to further weakness in consumer demand and inventory adjustments across all markets, with the management indicating that macro events and inventory adjustments have driven both DRAM and NAND demand well below near-term consumption, the analyst tells investors in a research note. Kumar adds that he would prefer to see a more constructive macro environment before turning more constructive on Micron shares.

ShowHide Related Items >><<
MU Micron
$50.04 /

-0.95 (-1.86%)

MU Micron
$50.04 /

-0.95 (-1.86%)

09/29/22 Summit Insights
Micron upgraded to Buy from Hold at Summit Insights
09/29/22 Lynx
Micron price target raised to $56 from $50 at Lynx
09/27/22 JPMorgan
JPMorgan cuts Micron target but says accumulate on pullbacks
09/27/22 UBS
Micron price target lowered to $75 from $80 at UBS
MU Micron
$50.04 /

-0.95 (-1.86%)

MU Micron
$50.04 /

-0.95 (-1.86%)

MU Micron
$50.04 /

-0.95 (-1.86%)

MU Micron
$50.04 /

-0.95 (-1.86%)

Hot Stocks
Cathie Wood's ARK Investment bought 951K shares of UiPath today  20:46
09/29/22
09/29
20:46
09/29/22
20:46
PATH

UiPath

$12.57 /

-0.385 (-2.97%)

 
ShowHide Related Items >><<
PATH UiPath
$12.57 /

-0.385 (-2.97%)

PATH UiPath
$12.57 /

-0.385 (-2.97%)

09/28/22 BofA
UiPath price target lowered to $18 from $20 at BofA
09/28/22 Credit Suisse
UiPath price target lowered to $30 from $37.50 at Credit Suisse
09/28/22 Barclays
UiPath price target lowered to $17 from $18 at Barclays
09/07/22 Canaccord
UiPath downgraded to Hold at Canaccord after 'largely disappointing' Q2 report
PATH UiPath
$12.57 /

-0.385 (-2.97%)

PATH UiPath
$12.57 /

-0.385 (-2.97%)

PATH UiPath
$12.57 /

-0.385 (-2.97%)

Hot Stocks
Cathie Wood's ARK Investment bought 141.5K shares of Rocket Lab today  20:45
09/29/22
09/29
20:45
09/29/22
20:45
RKLB

Rocket Lab

$4.16 /

-0.23 (-5.25%)

 
ShowHide Related Items >><<
RKLB Rocket Lab
$4.16 /

-0.23 (-5.25%)

RKLB Rocket Lab
$4.16 /

-0.23 (-5.25%)

09/13/22 Deutsche Bank
Rocket Lab named short-term idea at Deutsche Bank
08/31/22 Cowen
Rocket Lab upgraded to Outperform from Market Perform at Cowen
08/17/22 Stifel
Rocket Lab price target lowered to $15 from $18 at Stifel
08/15/22 Deutsche Bank
Rocket Lab price target raised to $15 from $14 at Deutsche Bank
RKLB Rocket Lab
$4.16 /

-0.23 (-5.25%)

RKLB Rocket Lab
$4.16 /

-0.23 (-5.25%)

RKLB Rocket Lab
$4.16 /

-0.23 (-5.25%)

Syndicate
dMY Squared Technology prices 6M unit IPO at $10 per unit » 20:44
09/29/22
09/29
20:44
09/29/22
20:44
DMYY

dMY Squared Technology

/

+

dMY Squared Technology…

dMY Squared Technology Group, Inc. is a blank check company whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. While the Company may pursue an initial business combination target in any industry or geographic region, the Company intends to focus its search for an initial business combination on companies within the professional service industry that provide accounting, legal, financial, advisory or other services to public companies or private companies that are in the process of becoming public companies with enterprise valuations in the range of $500 million to $2 billion. The Company intends to specifically focus on companies that have strong, consistent revenue growth and cash flow. Needham & Company, LLC is acting as the sole bookrunner for the offering.

Upgrade
Micron upgraded to Buy from Hold at Summit Insights » 20:43
09/29/22
09/29
20:43
09/29/22
20:43
MU

Micron

$50.04 /

-0.95 (-1.86%)

Summit Insights analyst…

Summit Insights analyst KinNgai Chan upgraded Micron to Buy from Hold. The DRAM demand-supply dynamics will remain challenging through early 2023 as demand weakness and customer inventory correction continue in the near term, though industry dynamics will improve once channel inventory correction is completed by the first half of 2023 and DDR5 DRAM ramps into volume, the analyst tells investors in a research note.

ShowHide Related Items >><<
MU Micron
$50.04 /

-0.95 (-1.86%)

MU Micron
$50.04 /

-0.95 (-1.86%)

09/29/22 Lynx
Micron price target raised to $56 from $50 at Lynx
09/27/22 JPMorgan
JPMorgan cuts Micron target but says accumulate on pullbacks
09/27/22 UBS
Micron price target lowered to $75 from $80 at UBS
09/27/22 JPMorgan
Micron price target lowered to $65 from $80 at JPMorgan
MU Micron
$50.04 /

-0.95 (-1.86%)

MU Micron
$50.04 /

-0.95 (-1.86%)

MU Micron
$50.04 /

-0.95 (-1.86%)

MU Micron
$50.04 /

-0.95 (-1.86%)

Earnings
Notable companies reporting before tomorrow's open » 20:25
09/29/22
09/29
20:25
09/29/22
20:25
CCL

Carnival

$9.16 /

-0.665 (-6.77%)

Notable companies…

Notable companies reporting before tomorrow's open, with earnings consensus, include Carnival (CCL), consensus (13c).

ShowHide Related Items >><<
CCL Carnival
$9.16 /

-0.665 (-6.77%)

CCL Carnival
$9.16 /

-0.665 (-6.77%)

09/20/22 Truist
Carnival price target raised to $10 from $8 at Truist
07/22/22 Truist
Carnival price target lowered to $8 from $15 at Truist
07/21/22 Stifel
Carnival selloff 'coming for sure' as equity raise will cause panic, says Stifel
07/04/22 HSBC
HSBC says too early to call inflection point for Carnival
CCL Carnival
$9.16 /

-0.665 (-6.77%)

  • 21
    Jul
CCL Carnival
$9.16 /

-0.665 (-6.77%)

CCL Carnival
$9.16 /

-0.665 (-6.77%)

CCL Carnival
$9.16 /

-0.665 (-6.77%)

Syndicate
Qomolangma Acquisition Corp prices 5M unit IPO at $10 per unit » 19:58
09/29/22
09/29
19:58
09/29/22
19:58
QOMOU

Qomolangma Acquisition Corp

/

+

Ladenburg Thalmann &…

Ladenburg Thalmann & Co. Inc. is acting as the sole bookrunner and the representative of the underwriters in the offering.

Hot Stocks
Citrix trading halted, news pending  19:50
09/29/22
09/29
19:50
09/29/22
19:50
CTXS

Citrix

$103.92 /

+0.06 (+0.06%)

 
ShowHide Related Items >><<
CTXS Citrix
$103.92 /

+0.06 (+0.06%)

CTXS Citrix
$103.92 /

+0.06 (+0.06%)

06/24/22 Stifel
Stifel keeps Buy rating on Zendesk, doesn't see 'end of the road quite yet'
02/23/22 Bernstein
Citrix downgraded to Market Perform from Outperform at Bernstein
01/24/22 Citi
Citrix downgraded to Sell from Neutral at Citi
01/21/22 Jefferies
Citrix lack of earnings date 'particularly unusual,' says Jefferies
CTXS Citrix
$103.92 /

+0.06 (+0.06%)

CTXS Citrix
$103.92 /

+0.06 (+0.06%)

Hot Stocks
EMA accepts Astellas Pharma's authorization application for Fezolinetant » 19:34
09/29/22
09/29
19:34
09/29/22
19:34
ALPMY

Astellas Pharma

$13.09 /

-0.03 (-0.23%)

Astellas Pharma…

Astellas Pharma "announced the European Medicines Agency has accepted for regulatory review the company's marketing authorization application for fezolinetant, an investigational oral, nonhormonal compound seeking approval for the treatment of moderate to severe vasomotor symptoms associated with menopause. VMS, characterized by hot flashes and/or night sweats, are common symptoms of menopause. The MAA is supported by results from the BRIGHT SKY program, which included three Phase 3 clinical trials that collectively enrolled over 2,800 women with VMS across Europe, the U.S. and Canada. Results from the SKYLIGHT 1 and SKYLIGHT 2 pivotal trials characterize the efficacy and safety of fezolinetant for the treatment of moderate to severe VMS associated with menopause. Data from the SKYLIGHT 4 safety study further characterizes the long-term safety profile of fezolinetant. Within the MAA, Astellas proposes a 45 mg daily dose, which is subject to the EMA's review."

ShowHide Related Items >><<
ALPMY Astellas Pharma
$13.09 /

-0.03 (-0.23%)

ALPMY Astellas Pharma
$13.09 /

-0.03 (-0.23%)

08/10/22 Citi
Astellas Pharma downgraded to Neutral from Buy at Citi
04/12/22 Citi
Astellas Pharma resumed with a Buy at Citi
02/23/22 Jefferies
Astellas Pharma downgraded to Hold from Buy at Jefferies
ALPMY Astellas Pharma
$13.09 /

-0.03 (-0.23%)

ALPMY Astellas Pharma
$13.09 /

-0.03 (-0.23%)

Hot Stocks
MoneyLion issues response to Consumer Financial Protection Bureau » 19:25
09/29/22
09/29
19:25
09/29/22
19:25
ML

MoneyLion

/

+

The company states:…

The company states: "MoneyLion has cooperated in good faith with the CFPB for over three years regarding our membership offering. Our innovative membership program helps service members and other customers save, invest, build credit and improve their overall financial lives. Despite our cooperation, the Bureau has chosen the sensationalist route of prioritizing headlines instead of engaging in constructive dialogue to address their questions and to achieve better consumer outcomes. We will vigorously defend against these false allegations to set the record straight as we continue to deliver innovative financial products that help our customers. The claims made by the Bureau about our membership offering, a product that represents a small subset of MoneyLion's business, are without merit. MoneyLion has the highest regard for its military and veteran customers and are committed to working with this important community to help them achieve better financial health."

ShowHide Related Items >><<
ML MoneyLion
/

+

ML MoneyLion
/

+

06/27/22 Loop Capital
MoneyLion initiated with a Buy at Loop Capital
03/11/22 Cantor Fitzgerald
MoneyLion price target lowered to $5 from $8 at Cantor Fitzgerald
11/22/21 Cantor Fitzgerald
MoneyLion initiated with an Overweight at Cantor Fitzgerald
11/22/21 Cantor Fitzgerald
MoneyLion initiated with an Overweight at Cantor Fitzgerald
ML MoneyLion
/

+

Hot Stocks
Tupperware announces settlement of SEC probe for divested entity » 19:03
09/29/22
09/29
19:03
09/29/22
19:03
TUP

Tupperware Brands

$6.66 /

-0.72 (-9.76%)

Tupperware Brands…

Tupperware Brands Corporation announced that it has reached a settlement with the U.S. Securities and Exchange Commission to fully resolve resolve its inquiry related to certain accounting practices of the now divested House of Fuller beauty business in Mexico from 2016 through the first quarter of 2020. Under terms of the settlement, Tupperware neither admits nor denies the SEC's findings and will pay an immaterial civil penalty, which was fully accrued in the second quarter of 2022. "One of our core principles at Tupperware is that we do what's right. When we first discovered certain accounting issues in our now divested beauty business in Mexico, we took swift action to conduct a thorough internal review and proactively address the findings to improve our processes, procedures and internal control framework in this former business," said Miguel Fernandez, CEO of Tupperware. "We are pleased to put this issue to rest and focus on moving the Tupperware brand into the future."

ShowHide Related Items >><<
TUP Tupperware Brands
$6.66 /

-0.72 (-9.76%)

TUP Tupperware Brands
$6.66 /

-0.72 (-9.76%)

08/04/22 Citi
Tupperware Brands price target raised to $11.50 from $8 at Citi
08/02/22 Citi
Tupperware Brands transferred with Neutral rating at Citi
05/05/22 DA Davidson
DA Davidson cuts Tupperware Brands to Neutral as macro and execution weigh on Q1
05/05/22 DA Davidson
Tupperware Brands downgraded to Neutral from Buy at DA Davidson
TUP Tupperware Brands
$6.66 /

-0.72 (-9.76%)

TUP Tupperware Brands
$6.66 /

-0.72 (-9.76%)

Hot Stocks
AVCtechnologies intends to effect a 1-for-15 reverse stock split » 18:56
09/29/22
09/29
18:56
09/29/22
18:56
AVCT

AVCtechnologies

/

+

American Virtual Cloud…

American Virtual Cloud Technologies announces that it intends to effect a 1-for-15 reverse stock split of its issued and outstanding shares of common stock. The Reverse Stock Split will become effective on September 30, 2022 upon filing with the Delaware Secretary of State of an amendment to the company's amended and restated certificate of incorporation, and the company's common stock is expected to begin trading on a split-adjusted basis when the market opens on October 3, 2022. The company's common stock will continue to trade on the Nasdaq Capital Market under the symbol "AVCT." The new CUSIP number for the common stock following the Reverse Stock Split will be 030382204.

ShowHide Related Items >><<
AVCT AVCtechnologies
/

+

AVCT AVCtechnologies
/

+

Hot Stocks
Morgan Stanley CEO: Unlikely we will have a hard landing » 18:36
09/29/22
09/29
18:36
09/29/22
18:36
MS

Morgan Stanley

$79.85 /

-1.52 (-1.87%)

In an interview on…

In an interview on CNBC's Mad Money, James Gorman said it's not totally surprising where we are today. "You can't have free money forever," he added. He feels inflation, unemployment, and interest rates all at 4% would be an ideal situation. There are reasons to be concerned, he said, but he hasn't seen enough yet to say it's a full blown crisis. The company is dealing with 15M clients and not seeing panic. U.S. banks are in the best shape financially in decades, he noted. Gorman feels "very good" about the company's financial position as it expects to retire 6%-7% of stock this year and offers a 3.5% dividend.

ShowHide Related Items >><<
MS Morgan Stanley
$79.85 /

-1.52 (-1.87%)

MS Morgan Stanley
$79.85 /

-1.52 (-1.87%)

09/12/22 Deutsche Bank
Morgan Stanley price target lowered to $92 from $105 at Deutsche Bank
09/06/22 Odeon Capital
Morgan Stanley downgraded to Sell from Hold at Odeon Capital
07/15/22 Oppenheimer
Morgan Stanley price target lowered to $93 from $97 at Oppenheimer
07/15/22 BMO Capital
Morgan Stanley price target lowered to $99 from $105 at BMO Capital
MS Morgan Stanley
$79.85 /

-1.52 (-1.87%)

MS Morgan Stanley
$79.85 /

-1.52 (-1.87%)

MS Morgan Stanley
$79.85 /

-1.52 (-1.87%)

MS Morgan Stanley
$79.85 /

-1.52 (-1.87%)

Earnings
Micron sees Q2 revenue range similar to Q1 » 18:35
09/29/22
09/29
18:35
09/29/22
18:35
MU

Micron

$50.04 /

-0.95 (-1.86%)

Sees bits up sequentially…

Sees bits up sequentially from Q3 to Q4. Guidance taken from Q4 earnings conference call.

ShowHide Related Items >><<
MU Micron
$50.04 /

-0.95 (-1.86%)

MU Micron
$50.04 /

-0.95 (-1.86%)

09/29/22 Lynx
Micron price target raised to $56 from $50 at Lynx
09/27/22 JPMorgan
JPMorgan cuts Micron target but says accumulate on pullbacks
09/27/22 UBS
Micron price target lowered to $75 from $80 at UBS
09/27/22 JPMorgan
Micron price target lowered to $65 from $80 at JPMorgan
MU Micron
$50.04 /

-0.95 (-1.86%)

MU Micron
$50.04 /

-0.95 (-1.86%)

MU Micron
$50.04 /

-0.95 (-1.86%)

MU Micron
$50.04 /

-0.95 (-1.86%)

Hot Stocks
Amylyx announces FDA approval of RELYVRIO for treatment of ALS » 18:31
09/29/22
09/29
18:31
09/29/22
18:31
AMLX

Amylyx

$30.14 /

+0.96 (+3.29%)

Amylyx Pharmaceuticals…

Amylyx Pharmaceuticals announced that the U.S. Food and Drug Administration has approved RELYVRIO for the treatment of adults with amyotrophic lateral sclerosis. RELYVRIO significantly slowed the loss of physical function in people living with ALS in a randomized, placebo-controlled clinical trial. RELYVRIO can be taken as a monotherapy or with existing approved treatments. "Today's FDA approval of RELYVRIO is an exciting milestone for the ALS community and is a major step toward achieving our mission to one day end the suffering caused by neurodegenerative diseases," said Joshua Cohen and Justin Klee, Co-CEOs of Amylyx. "We want to give a heartfelt thank you to the broader ALS community, including healthcare professionals and those living with ALS, for their guidance, support of our clinical programs, and for sharing their experiences with us. Their stories inspired us and helped our team to better understand the ALS clock, instilling in us a deep sense of urgency that will continue to drive us forward. This is just the beginning and there is much more to be done."

ShowHide Related Items >><<
AMLX Amylyx
$30.14 /

+0.96 (+3.29%)

AMLX Amylyx
$30.14 /

+0.96 (+3.29%)

09/08/22 SVB Securities
Amylyx price target raised to $50 from $31 at SVB Securities
09/08/22 Citi
Amylyx shares should rally $20 or more today, says Citi
07/06/22 Citi
Amylyx price target raised to $37 from $33 at Citi
06/14/22 Citi
Amylyx price target raised to $33 from $32 at Citi
AMLX Amylyx
$30.14 /

+0.96 (+3.29%)

  • 07
    Jan
AMLX Amylyx
$30.14 /

+0.96 (+3.29%)

AMLX Amylyx
$30.14 /

+0.96 (+3.29%)

AMLX Amylyx
$30.14 /

+0.96 (+3.29%)

On The Fly
Fly Intel: After-Hours Movers » 18:18
09/29/22
09/29
18:18
09/29/22
18:18
CMTL

Comtech

$9.86 /

-0.42 (-4.09%)

, AMLX

Amylyx

$30.14 /

+0.96 (+3.29%)

, NKE

Nike

$95.40 /

-3.3 (-3.34%)

, UAA

Under Armour

$7.37 /

-0.545 (-6.89%)

, FL

Foot Locker

$32.70 /

-2.24 (-6.41%)

, SKX

Skechers

$34.09 /

-0.305 (-0.89%)

, MU

Micron

$50.04 /

-0.95 (-1.86%)

, RCII

Rent-A-Center

$22.32 /

-1.21 (-5.14%)

Check out this evening's…

ShowHide Related Items >><<
UAA Under Armour
$7.37 /

-0.545 (-6.89%)

SKX Skechers
$34.09 /

-0.305 (-0.89%)

RCII Rent-A-Center
$22.32 /

-1.21 (-5.14%)

NKE Nike
$95.40 /

-3.3 (-3.34%)

MU Micron
$50.04 /

-0.95 (-1.86%)

FL Foot Locker
$32.70 /

-2.24 (-6.41%)

CMTL Comtech
$9.86 /

-0.42 (-4.09%)

AMLX Amylyx
$30.14 /

+0.96 (+3.29%)

CMTL Comtech
$9.86 /

-0.42 (-4.09%)

06/15/22 Jefferies
Comtech downgraded to Hold from Buy at Jefferies
06/13/22 Noble Capital
Comtech upgraded to Outperform from Market Perform at Noble Capital
06/10/22 Citi
Comtech price target lowered to $14 from $20 at Citi
10/05/21 Noble Capital
Comtech downgraded to Market Perform from Outperform at Noble Capital
AMLX Amylyx
$30.14 /

+0.96 (+3.29%)

09/08/22 SVB Securities
Amylyx price target raised to $50 from $31 at SVB Securities
09/08/22 Citi
Amylyx shares should rally $20 or more today, says Citi
07/06/22 Citi
Amylyx price target raised to $37 from $33 at Citi
06/14/22 Citi
Amylyx price target raised to $33 from $32 at Citi
NKE Nike
$95.40 /

-3.3 (-3.34%)

09/28/22 JPMorgan
JPMorgan sees 'peak negativity' in Nike ahead of results
09/23/22 Jefferies
Nike price target lowered to $130 from $155 at Jefferies
09/22/22 Morgan Stanley
Morgan Stanley trims Nike target, says Q1 earnings 'unlikely to move needle'
09/22/22 RBC Capital
Nike initiated with an Outperform at RBC Capital
UAA Under Armour
$7.37 /

-0.545 (-6.89%)

09/27/22 Baird
Baird removes negative 'Fresh Pick' on Under Armour amid less-defensive shift
09/27/22 Baird
Baird adds positive 'Fresh Pick' on Planet Fitness amid less-defensive shift
08/04/22 Williams Trading
Under Armour downgraded to Sell from Hold at Williams Trading
08/04/22 Barclays
Under Armour price target lowered to $12 from $14 at Barclays
FL Foot Locker
$32.70 /

-2.24 (-6.41%)

08/23/22 Credit Suisse
Foot Locker price target raised to $40 from $31 at Credit Suisse
08/23/22 Deutsche Bank
Foot Locker price target raised to $34 from $31 at Deutsche Bank
08/23/22 UBS
Foot Locker price target raised to $39 from $29 at UBS
08/22/22 B. Riley
Foot Locker price target raised to $36 from $33 at B. Riley
SKX Skechers
$34.09 /

-0.305 (-0.89%)

07/27/22 Wedbush
Skechers price target lowered to $42 from $48 at Wedbush
07/25/22 Deutsche Bank
Skechers price target lowered to $51 from $64 at Deutsche Bank
07/20/22 Stifel
Skechers price target lowered to $45 from $61 at Stifel
07/15/22 UBS
Skechers price target lowered to $56 from $67 at UBS
MU Micron
$50.04 /

-0.95 (-1.86%)

09/29/22 Lynx
Micron price target raised to $56 from $50 at Lynx
09/27/22 JPMorgan
JPMorgan cuts Micron target but says accumulate on pullbacks
09/27/22 UBS
Micron price target lowered to $75 from $80 at UBS
09/27/22 JPMorgan
Micron price target lowered to $65 from $80 at JPMorgan
RCII Rent-A-Center
$22.32 /

-1.21 (-5.14%)

06/29/22 Stephens
Rent-A-Center downgraded to Equal Weight from Overweight at Stephens
02/25/22 KeyBanc
Rent-A-Center price target lowered to $44 from $68 at KeyBanc
02/25/22 Raymond James
Rent-A-Center downgraded to Outperform from Strong Buy at Raymond James
11/05/21 Raymond James
Rent-A-Center price target lowered to $65 from $70 at Raymond James
UAA Under Armour
$7.37 /

-0.545 (-6.89%)

SKX Skechers
$34.09 /

-0.305 (-0.89%)

RCII Rent-A-Center
$22.32 /

-1.21 (-5.14%)

NKE Nike
$95.40 /

-3.3 (-3.34%)

MU Micron
$50.04 /

-0.95 (-1.86%)

FL Foot Locker
$32.70 /

-2.24 (-6.41%)

CMTL Comtech
$9.86 /

-0.42 (-4.09%)

AMLX Amylyx
$30.14 /

+0.96 (+3.29%)

  • 07
    Jan
UAA Under Armour
$7.37 /

-0.545 (-6.89%)

SKX Skechers
$34.09 /

-0.305 (-0.89%)

NKE Nike
$95.40 /

-3.3 (-3.34%)

MU Micron
$50.04 /

-0.95 (-1.86%)

AMLX Amylyx
$30.14 /

+0.96 (+3.29%)

UAA Under Armour
$7.37 /

-0.545 (-6.89%)

SKX Skechers
$34.09 /

-0.305 (-0.89%)

NKE Nike
$95.40 /

-3.3 (-3.34%)

MU Micron
$50.04 /

-0.95 (-1.86%)

FL Foot Locker
$32.70 /

-2.24 (-6.41%)

CMTL Comtech
$9.86 /

-0.42 (-4.09%)

AMLX Amylyx
$30.14 /

+0.96 (+3.29%)

UAA Under Armour
$7.37 /

-0.545 (-6.89%)

SKX Skechers
$34.09 /

-0.305 (-0.89%)

NKE Nike
$95.40 /

-3.3 (-3.34%)

MU Micron
$50.04 /

-0.95 (-1.86%)

FL Foot Locker
$32.70 /

-2.24 (-6.41%)

AMLX Amylyx
$30.14 /

+0.96 (+3.29%)

Hot Stocks
Rent-A-Center sinks 18% after cutting Q3 guidance, naming new CFO  18:04
09/29/22
09/29
18:04
09/29/22
18:04
RCII

Rent-A-Center

$22.32 /

-1.21 (-5.14%)

 
ShowHide Related Items >><<
RCII Rent-A-Center
$22.32 /

-1.21 (-5.14%)

RCII Rent-A-Center
$22.32 /

-1.21 (-5.14%)

06/29/22 Stephens
Rent-A-Center downgraded to Equal Weight from Overweight at Stephens
02/25/22 KeyBanc
Rent-A-Center price target lowered to $44 from $68 at KeyBanc
02/25/22 Raymond James
Rent-A-Center downgraded to Outperform from Strong Buy at Raymond James
11/05/21 Raymond James
Rent-A-Center price target lowered to $65 from $70 at Raymond James
RCII Rent-A-Center
$22.32 /

-1.21 (-5.14%)

Hot Stocks
Ready Capital announces increase to share buyback program by $25M » 18:02
09/29/22
09/29
18:02
09/29/22
18:02
RC

Ready Capital

$9.76 /

-0.785 (-7.44%)

Ready Capital…

Ready Capital "announced the Board of Directors authorized an increase in the size of the Company's existing stock repurchase program by an additional $25.0M, bringing the total amount authorized under the program to $50.0M."

ShowHide Related Items >><<
RC Ready Capital
$9.76 /

-0.785 (-7.44%)

RC Ready Capital
$9.76 /

-0.785 (-7.44%)

09/08/22 B. Riley
Ready Capital price target lowered to $16 from $18 at B. Riley
06/28/22 Piper Sandler
Ready Capital price target lowered to $14 from $16 at Piper Sandler
03/11/22 BTIG
Ready Capital coverage transferred at BTIG
12/03/21 B. Riley
Ready Capital price target raised to $18 from $17 at B. Riley
RC Ready Capital
$9.76 /

-0.785 (-7.44%)

  • 12
    Jan
Periodicals
Boeing pauses South Carolina 787 plant operations amid storm, Bloomberg says  18:00
09/29/22
09/29
18:00
09/29/22
18:00
BA

Boeing

$125.35 /

-8.035 (-6.02%)

 
ShowHide Related Items >><<
BA Boeing
$125.35 /

-8.035 (-6.02%)

BA Boeing
$125.35 /

-8.035 (-6.02%)

09/27/22 Morgan Stanley
Boeing's China and MAX 10 risks overdone at current levels, says Morgan Stanley
09/23/22 BofA
Losing Xiamen to Airbus another setback for Boeing, says BofA
09/14/22 Jefferies
Woodward downgraded to Hold from Buy at Jefferies
09/08/22 Morgan Stanley
Boeing price target raised to $233 from $215 at Morgan Stanley
BA Boeing
$125.35 /

-8.035 (-6.02%)

BA Boeing
$125.35 /

-8.035 (-6.02%)

BA Boeing
$125.35 /

-8.035 (-6.02%)

BA Boeing
$125.35 /

-8.035 (-6.02%)

Hot Stocks
United Natural Foods increasing investment in Shoppers banner » 17:52
09/29/22
09/29
17:52
09/29/22
17:52
UNFI

United Natural Foods

$33.56 /

-2.475 (-6.87%)

United Natural Foods is…

United Natural Foods is reacquiring three former store locations which had previously been sold and remodeling two existing store locations, as part of its commitment to build its Shoppers banner by adding to and improving the stores in its portfolio. In addition to the three new locations in Maryland, Shoppers is scheduled to complete in early October remodels at their stores in Forestville, Md.

ShowHide Related Items >><<
UNFI United Natural Foods
$33.56 /

-2.475 (-6.87%)

UNFI United Natural Foods
$33.56 /

-2.475 (-6.87%)

09/28/22 MKM Partners
United Natural Foods price target lowered to $63 from $69 at MKM Partners
09/28/22 Deutsche Bank
United Natural Foods price target lowered to $46 from $54 at Deutsche Bank
09/28/22 Wells Fargo
United Natural Foods price target lowered to $40 from $45 at Wells Fargo
09/28/22 BMO Capital
United Natural Foods price target lowered to $40 from $45 at BMO Capital
UNFI United Natural Foods
$33.56 /

-2.475 (-6.87%)

UNFI United Natural Foods
$33.56 /

-2.475 (-6.87%)

UNFI United Natural Foods
$33.56 /

-2.475 (-6.87%)

Periodicals
China certifies C919 plane in challenge to Airbus, Boeing, Reuters says » 17:44
09/29/22
09/29
17:44
09/29/22
17:44
BA

Boeing

$125.35 /

-8.035 (-6.02%)

, EADSY

Airbus

$21.58 /

-0.272 (-1.24%)

China hosted a ceremony…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EADSY Airbus
$21.58 /

-0.272 (-1.24%)

BA Boeing
$125.35 /

-8.035 (-6.02%)

BA Boeing
$125.35 /

-8.035 (-6.02%)

09/27/22 Morgan Stanley
Boeing's China and MAX 10 risks overdone at current levels, says Morgan Stanley
09/23/22 BofA
Losing Xiamen to Airbus another setback for Boeing, says BofA
09/14/22 Jefferies
Woodward downgraded to Hold from Buy at Jefferies
09/08/22 Morgan Stanley
Boeing price target raised to $233 from $215 at Morgan Stanley
EADSY Airbus
$21.58 /

-0.272 (-1.24%)

09/26/22 JPMorgan
Airbus price target lowered to EUR 155 from EUR 175 at JPMorgan
09/06/22 Goldman Sachs
Airbus downgraded to Buy from Conviction Buy at Goldman Sachs
08/03/22 Citi
Airbus price target raised to EUR 171 at Citi
EADSY Airbus
$21.58 /

-0.272 (-1.24%)

BA Boeing
$125.35 /

-8.035 (-6.02%)

EADSY Airbus
$21.58 /

-0.272 (-1.24%)

BA Boeing
$125.35 /

-8.035 (-6.02%)

EADSY Airbus
$21.58 /

-0.272 (-1.24%)

BA Boeing
$125.35 /

-8.035 (-6.02%)

BA Boeing
$125.35 /

-8.035 (-6.02%)

Hot Stocks
Nike sees Q2 revenue up low double digits, gross margins to decline 350-400bps » 17:43
09/29/22
09/29
17:43
09/29/22
17:43
NKE

Nike

$95.40 /

-3.3 (-3.34%)

Says: "For the…

Says: "For the second quarter specifically, we expect reported revenue to grow low double digits on strong consumer demand despite 900 basis points of foreign exchange headwinds. We expect second quarter gross margins to decline approximately 350 to 400 basis points versus the prior year, the largest impact across the fiscal year as we discount out-of-season product more aggressively in a largely promotional marketplace. This will require higher markdowns in our own channels and through wholesale partners. The second quarter also compares to last year's record level of full price realization and includes headwinds from freight, logistics and other supply chain costs as well as foreign exchange." Comments taken from Q1 earnings conference call.

ShowHide Related Items >><<
NKE Nike
$95.40 /

-3.3 (-3.34%)

NKE Nike
$95.40 /

-3.3 (-3.34%)

09/28/22 JPMorgan
JPMorgan sees 'peak negativity' in Nike ahead of results
09/23/22 Jefferies
Nike price target lowered to $130 from $155 at Jefferies
09/22/22 Morgan Stanley
Morgan Stanley trims Nike target, says Q1 earnings 'unlikely to move needle'
09/22/22 RBC Capital
Nike initiated with an Outperform at RBC Capital
NKE Nike
$95.40 /

-3.3 (-3.34%)

NKE Nike
$95.40 /

-3.3 (-3.34%)

NKE Nike
$95.40 /

-3.3 (-3.34%)

NKE Nike
$95.40 /

-3.3 (-3.34%)

Hot Stocks
Nike CFO says FY23 gross margins to decline 200-250bps in FY23 » 17:40
09/29/22
09/29
17:40
09/29/22
17:40
NKE

Nike

$95.40 /

-3.3 (-3.34%)

Sees negative FX headwind…

Sees negative FX headwind at about $4B.

ShowHide Related Items >><<
NKE Nike
$95.40 /

-3.3 (-3.34%)

NKE Nike
$95.40 /

-3.3 (-3.34%)

09/28/22 JPMorgan
JPMorgan sees 'peak negativity' in Nike ahead of results
09/23/22 Jefferies
Nike price target lowered to $130 from $155 at Jefferies
09/22/22 Morgan Stanley
Morgan Stanley trims Nike target, says Q1 earnings 'unlikely to move needle'
09/22/22 RBC Capital
Nike initiated with an Outperform at RBC Capital
NKE Nike
$95.40 /

-3.3 (-3.34%)

NKE Nike
$95.40 /

-3.3 (-3.34%)

NKE Nike
$95.40 /

-3.3 (-3.34%)

NKE Nike
$95.40 /

-3.3 (-3.34%)

Hot Stocks
Nike CFO says China business performance, inventory management ahead of plan » 17:37
09/29/22
09/29
17:37
09/29/22
17:37
NKE

Nike

$95.40 /

-3.3 (-3.34%)

Says: "Brand…

Says: "Brand strength is our competitive advantage, with NIKE setting the pace as Chinese consumers' #1 cool and #1 favorite brand, further extending our lead among teams."

ShowHide Related Items >><<
NKE Nike
$95.40 /

-3.3 (-3.34%)

NKE Nike
$95.40 /

-3.3 (-3.34%)

09/28/22 JPMorgan
JPMorgan sees 'peak negativity' in Nike ahead of results
09/23/22 Jefferies
Nike price target lowered to $130 from $155 at Jefferies
09/22/22 Morgan Stanley
Morgan Stanley trims Nike target, says Q1 earnings 'unlikely to move needle'
09/22/22 RBC Capital
Nike initiated with an Outperform at RBC Capital
NKE Nike
$95.40 /

-3.3 (-3.34%)

NKE Nike
$95.40 /

-3.3 (-3.34%)

NKE Nike
$95.40 /

-3.3 (-3.34%)

NKE Nike
$95.40 /

-3.3 (-3.34%)

Hot Stocks
Miniso's Chairman of the Board to purchase up to $5M in shares » 17:33
09/29/22
09/29
17:33
09/29/22
17:33
MNSO

Miniso

$4.99 /

+0.13 (+2.67%)

Miniso's Chairman of…

Miniso's Chairman of the Board of directors, CEO and the controlling shareholder of the company, Guofu Ye, has informed the company of his intention to use his personal funds to purchase up to an aggregate of $5M worth of the company's ordinary shares and/or ADS, representing approximately 0.3% of the total issued share capital of the company based on the ADS closing price as of September 28, within the next twelve months. At this date, Ye is interested in approximately 61.6% of the total issued shares of the company through entities controlled by him and/or his spouse.

ShowHide Related Items >><<
MNSO Miniso
$4.99 /

+0.13 (+2.67%)

MNSO Miniso
$4.99 /

+0.13 (+2.67%)

07/13/22 Goldman Sachs
Miniso price target lowered to $11.90 from $12.20 at Goldman Sachs
06/13/22 Jefferies
Miniso initiated with a Buy at Jefferies
MNSO Miniso
$4.99 /

+0.13 (+2.67%)

MNSO Miniso
$4.99 /

+0.13 (+2.67%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.